EcoDrugPlus

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSPVAG00000009271
Gene Symbol: DGAT1
1 Cross references
260 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSPVAG00000010253
Gene Symbol: DHODH
1 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSPVAG00000000332
Gene Symbol: DPYD
1 Cross references
220 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSPVAG00000005951
Gene Symbol: DDR2
1 Cross references
265 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSPVAG00000014124
Gene Symbol: DRD1
1 Cross references
261 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSPVAG00000012853
Gene Symbol: DRD2
1 Cross references
219 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSPVAG00000008519
Gene Symbol: DRD3
1 Cross references
206 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSPVAG00000003713
Gene Symbol: ENPP2
1 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 2

Ensembl ID : ENSPVAG00000001492
Gene Symbol: EGLN2
1 Cross references
190 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSPVAG00000002170
Gene Symbol: EGLN3
1 Cross references
208 Possible Orthologues:

Elastase, Neutrophil Expressed

Ensembl ID : ENSPVAG00000005848
Gene Symbol: ELANE
1 Cross references
102 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSPVAG00000011259
Gene Symbol: EPAS1
1 Cross references
222 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).